Efficacy of Eltrombopag Plus Lenalidomide Combination Therapy in Patients With IPSS Low and Intermediate-risk Myelodysplastic Syndrome With Isolated del5q
Clinical trial NCT02928419 · TERMINATED
Trial details
- NCT number
- NCT02928419
- Sponsor
- Associazione Qol-one
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2018-09-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.